Apple, J&J Launch New mHealth Study Targeting Wearables and AFib
Price: $ 108.00
4.9(710)
Apple and Johnson & Johnson are launching a new mHealth study aimed at testing the capabilities of the Apple Watch to detect and treat atrial fibrillation in seniors.
Wearable Heart Monitor Detects Previously Undiagnosed Atrial
Wearable Heart Monitor Detects Previously Undiagnosed Atrial
Wearable health monitors not always reliable, study shows
Wearable Devices in Cardiovascular Medicine
Apple, Johnson & Johnson study to predict stroke risk with Apple Watch
Pandemic-proof recruitment and engagement in a fully decentralized
Full article: Lessons learned in the Apple Heart Study and
Does early detection of atrial fibrillation reduce the risk of
Pandemic-proof recruitment and engagement in a fully decentralized
FDA clears Apple Watch's 'AFib History' feature
Wearable Heart Monitor Detects Previously Undiagnosed Atrial